Scientists are intently observing this treatment, a novel medication targeting tau tangles , a crucial hallmark of Alzheimer's . Unlike many past efforts focused on amyloid plaques, Semorinemab intends to https://semorinemab-monoclonal-a373225.mpeblog.com/76022603/semorinemab-a-new-possibility-for-the-condition